Baxter International Inc.
BAX · NYSEBAX has an annual revenue baseline of $11.2B, latest revenue marker of $2.7B Q1 2026, annual net income of -$957M and cash of $2.02B. The thesis depends on revenue durability, margins, cash conversion and balance-sheet discipline.
Valuation is limited to admins for now.
The valuation workbench is hidden from non-admin users until market-data licensing and trust disclosures are production-ready.